Each visit should cover your weight trajectory, side effect management, metabolic markers (periodic lab work), medication adherence, and any new symptoms or concerns
Gallbladder disease risk may be increased with GLP-1 receptor agonists, particularly with substantial weight loss
Retatrutide does not directly suppress testosterone production
Below are this phase 2s table of key outcomes, alongside retatrutides effects versus other drugs for fatty liver disease
A 20mg vial reaches twice the concentration of a 10mg vial at the same fill volume, so a volume carried over from 10mg work will not reproduce a 10mg stock concentration
Compounded medications are not FDA approved and carry risks related to inconsistent potency, sterility, and formulation quality